article thumbnail

Biopharma struggling to find talent with adequate digital skills

European Pharmaceutical Review

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.

article thumbnail

Innovation key for boosting UK biopharma competitiveness

European Pharmaceutical Review

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Resolving challenges with product recovery in biopharma manufacturing

Pharmaceutical Technology

Breakthroughs in therapies containing monoclonal antibodies (mAbs) are showing ever-greater potential in treating a range of diseases, alongside biopharma manufacturers facing the challenge of keeping up with demand for production while controlling costs. This can result in reductions in costs for our customers.”

article thumbnail

University of Oklahoma to open bioprocessing training facility

European Pharmaceutical Review

Siddique noted that four of the state’s biggest biopharma companies will be located close to the site. The EDA will also finance five more Oklahoma-based projects: Biomanufacturing Workforce Training Center. OU Health Stephenson Cancer Center for Therapeutics – Translational Research Labs. Oklahoma Bioscience Cluster Initiative.

article thumbnail

Emerging Investigators Are Pivotal for Meeting Current, Future Drug Development Needs

MedCity News

We must engage, train and support more physicians as investigators to enable the opportunity for their patients to have access to clinical trials. As an industry, we should be adding anywhere from 10% to 20% new investigators every year to meet the patient access needs for clinical trials.

article thumbnail

A holistic approach to safeguard data integrity in Biopharma manufacturing

European Pharmaceutical Review

In Biopharma, where precision and accuracy are important, integrating robust processes is not just a necessity but a strategic imperative. Especially in complex ecosystems like the Biopharma ones, data integrity requires the collaboration of multiple departments. They serve as the foundation upon which data integrity is built.

article thumbnail

New medicines manufacturing centre to enhance UK talent

European Pharmaceutical Review

It will build on existing infrastructure and best practice, and deliver sustainable, end-to-end training provision. Last month in late August 2023, another round of funding to help boost the UK medicines manufacturing sector and support innovation in the biopharma industry was announced.